Arcturus Therapeutics

Arcturus reports positive results for sa-mRNA COVID boosters in phase 1/2 trial

19 September 2023

Anika Sharma

Amid a shrinking COVID-19 vaccine market, Arcturus Therapeutics is forging ahead with its mRNA candidate, revealing promising early data demonstrating ...

Japan Invests $115M in Arcturus’ mRNA Manufacturing Joint Venture

Japanese Government Backs Arcalis with $115 Million Grants for mRNA Vaccine Production

15 August 2023

SG Tylor

Following Daiichi Sankyo’s recent accomplishment of securing Japan’s first mRNA vaccine approval, a potential competitor has emerged backed by significant ...